Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for INVO Fertility (IVF) over the last 16 years, with Q3 2025 value amounting to $3.4 million.

  • INVO Fertility's Shares Outstanding (Weighted Average) rose 309375.08% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 309375.08%. This contributed to the annual value of $309539.0 for FY2024, which is 15954.1% up from last year.
  • Per INVO Fertility's latest filing, its Shares Outstanding (Weighted Average) stood at $3.4 million for Q3 2025, which was up 309375.08% from $397440.0 recorded in Q2 2025.
  • INVO Fertility's Shares Outstanding (Weighted Average)'s 5-year high stood at $12.1 million during Q1 2022, with a 5-year trough of $100276.0 in Q2 2024.
  • For the 5-year period, INVO Fertility's Shares Outstanding (Weighted Average) averaged around $3.4 million, with its median value being $622507.0 (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first plummeted by 9483.43% in 2023, then skyrocketed by 309375.08% in 2025.
  • INVO Fertility's Shares Outstanding (Weighted Average) (Quarter) stood at $10.6 million in 2021, then tumbled by 94.3% to $606130.0 in 2022, then crashed by 80.32% to $119264.0 in 2023, then skyrocketed by 159.54% to $309539.0 in 2024, then soared by 1013.79% to $3.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $3.4 million for Q3 2025, versus $397440.0 for Q2 2025 and $1.4 million for Q1 2025.